DTC Ad Crackdown: US FDA Focuses On Compounded GLP-1 Marketers

 
• By Cathy Kelly and Sue Sutter
  
A flurry of warning letters were posted by the FDA days after announcing a renewed focus on DTC advertising reforms. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Marketing & Advertising

More from Compliance